Skip to main content

Table 3 Summary of the interventions

From: Dental implants and risk of bleeding in patients on oral anticoagulants: a systematic review and meta-analysis

Anticoagulant groups Incidence of adverse events (total) Relative risk adverse event (95% CI) Number of participants (studies)
Group A (%) Group B (%)
Continuation of anticoagulants (group A) vs no anticoagulant (group B) 29 (8.1) 35 (3.0) 2.30 [1.25, 4.24] 1384 (6)
Pause of anticoagulant (group A) vs no anticoagulant (group B) 8 (19.5) 2 (4.7) 1.45 [0.22, 9.70] 83 (2)